Roberta Mazzone

752 total citations
9 papers, 468 citations indexed

About

Roberta Mazzone is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Roberta Mazzone has authored 9 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Roberta Mazzone's work include Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (3 papers) and Acute Myeloid Leukemia Research (2 papers). Roberta Mazzone is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (3 papers) and Acute Myeloid Leukemia Research (2 papers). Roberta Mazzone collaborates with scholars based in Italy, France and Australia. Roberta Mazzone's co-authors include Antonello Mai, Clemens Zwergel, Sérgio Valente, Marco Artico, Massimo Ralli, Samanta Taurone, Antonio Greco, Paola B. Arimondo, Carmela Fimognari and Dante Rotili and has published in prestigious journals such as Journal of Biological Chemistry, European Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Roberta Mazzone

9 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Mazzone Italy 9 281 91 80 54 51 9 468
James A. Zanghi United States 10 441 1.6× 101 1.1× 70 0.9× 76 1.4× 53 1.0× 16 578
Xupeng Yue China 13 333 1.2× 78 0.9× 96 1.2× 43 0.8× 214 4.2× 16 532
Milena Vuica‐Ross United States 12 465 1.7× 93 1.0× 130 1.6× 44 0.8× 74 1.5× 20 679
Windy Berkofsky‐Fessler United States 9 341 1.2× 94 1.0× 113 1.4× 59 1.1× 56 1.1× 15 495
Reshmi Parameswaran United States 13 219 0.8× 243 2.7× 178 2.2× 42 0.8× 37 0.7× 27 525
Daniel R. Matson United States 12 368 1.3× 84 0.9× 120 1.5× 31 0.6× 44 0.9× 31 604
I‐Ying Lin Taiwan 12 214 0.8× 177 1.9× 40 0.5× 37 0.7× 46 0.9× 14 413
Aloke Sarkar United States 14 273 1.0× 100 1.1× 105 1.3× 29 0.5× 69 1.4× 20 492
Zhenqing Feng China 12 201 0.7× 77 0.8× 179 2.2× 28 0.5× 48 0.9× 30 408
Eugene Froimchuk United States 9 329 1.2× 130 1.4× 67 0.8× 85 1.6× 51 1.0× 9 543

Countries citing papers authored by Roberta Mazzone

Since Specialization
Citations

This map shows the geographic impact of Roberta Mazzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Mazzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Mazzone more than expected).

Fields of papers citing papers by Roberta Mazzone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Mazzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Mazzone. The network helps show where Roberta Mazzone may publish in the future.

Co-authorship network of co-authors of Roberta Mazzone

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Mazzone. A scholar is included among the top collaborators of Roberta Mazzone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Mazzone. Roberta Mazzone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mazzone, Roberta, Irene del Molino del Barrio, Annalidia Donato, et al.. (2020). Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells. Journal of Biological Chemistry. 295(52). 17973–17985. 9 indexed citations
2.
Zwergel, Clemens, Elisabetta Di Bello, Rossella Fioravanti, et al.. (2020). Novel Pyridine‐Based Hydroxamates and 2′‐Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity. ChemMedChem. 16(6). 989–999. 12 indexed citations
3.
Mazzone, Roberta, Clemens Zwergel, Marco Artico, et al.. (2019). The emerging role of epigenetics in human autoimmune disorders. Clinical Epigenetics. 11(1). 34–34. 191 indexed citations
4.
Manara, Maria Cristina, Sérgio Valente, Giordano Nicoletti, et al.. (2018). A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy. Molecular Cancer Therapeutics. 17(9). 1881–1892. 38 indexed citations
5.
Bouchut, Anne, Dante Rotili, Christine Pierrot, et al.. (2018). Identification of novel quinazoline derivatives as potent antiplasmodial agents. European Journal of Medicinal Chemistry. 161. 277–291. 47 indexed citations
6.
Milelli, Andrea, Chiara Marchetti, Eleonora Turrini, et al.. (2018). Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(6). 1001–1004. 23 indexed citations
7.
Mazzone, Roberta, Clemens Zwergel, Antonello Mai, & Sérgio Valente. (2017). Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy. Clinical Epigenetics. 9(1). 59–59. 118 indexed citations
8.
Mazzone, Roberta, et al.. (2016). The impact of family owners’ monitoring on CEO turnover decisions and the role of trust. Journal of Management & Governance. 21(3). 599–621. 12 indexed citations
9.
Foà, Robin, Federico Bussolino, Anna Guarini, et al.. (1985). Release of platelet-activating factor in human leukemia.. PubMed. 45(9). 4483–5. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026